Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arena Pharmaceuticals Inc. ARNA

Healthcare Biotechnology
Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimm...


NDAQ:ARNA - Post by User

Arena Pharmaceuticals Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by EarningsImpact1on Jul 18, 2013 4:12am
389 Views
Post# 21614826

Wells-Fargo-Healthcare-Conference Updates

Wells-Fargo-Healthcare-Conference UpdatesTalks about BELVIQ in general and also about their pipeline.

[url=https://www.earningsimpact.com/Transcript/81730/ARNA/Arena-Pharmaceuticals%2c-Inc----2013-Wells-Fargo-Securities-Research-and-Economics-Healthcare-Conference]Read here[/url]
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities